Patents by Inventor Nobuyuki Kurusu

Nobuyuki Kurusu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8252810
    Abstract: Compounds represented by formula (I) and pharmaceutically acceptable salts thereof have excellent sodium channel inhibitory action and are useful as therapeutic agents and analgesics for various kinds of neuralgia, neuropathy, epilepsy, insomnia, premature ejaculation and the like. wherein Q represents ethylene, etc., R1, R2 and R3 represent hydrogen, etc., X1 represents C1-6 alkylene, etc., X2 represents C1-6 alkylene, etc., A1 represents a 5- to 6-membered heterocyclic group, etc., and A2 represents C6-14 aryl, etc.
    Type: Grant
    Filed: February 9, 2009
    Date of Patent: August 28, 2012
    Assignee: Eisai R&D Management Co., Ltd.
    Inventors: Fumihiro Ozaki, Motohiro Soejima, Tasuku Ishida, Yoshihiko Norimine, Nobuyuki Kurusu, Eriko Doi, Toshihiko Kaneko, Daiju Hasegawa, Kiyoaki Kobayashi, Noboru Yamamoto
  • Publication number: 20100331310
    Abstract: Compounds represented by formula (I) and pharmaceutically acceptable salts thereof have excellent sodium channel inhibitory action and are useful as therapeutic agents and analgesics for various kinds of neuralgia, neuropathy, epilepsy, insomnia, premature ejaculation and the like. wherein Q represents ethylene, etc., R1, R2 and R3 represent hydrogen, etc., X1 represents C1-6 alkylene, etc., X2 represents C1-6 alkylene, etc., A1 represents a 5- to 6-membered heterocyclic group, etc., and A2 represents C6-14 aryl, etc.
    Type: Application
    Filed: February 9, 2009
    Publication date: December 30, 2010
    Inventors: Fumihiro Ozaki, Motohiro Soejima, Tasuku Ishida, Yoshihiko Norimine, Nobuyuki Kurusu, Eriko Doi, Toshihiko Kaneko, Daiju Hasegawa, Kiyoaki Kobayashi, Noboru Yamamoto
  • Publication number: 20090270369
    Abstract: Compounds represented by formula (I) and pharmaceutically acceptable salts thereof have excellent sodium channel inhibitory action and are useful as therapeutic agents and analgesics for various kinds of neuralgia, neuropathy, epilepsy, insomnia, premature ejaculation and the like. wherein Q represents ethylene, etc., R1, R2 and R3 represent hydrogen, etc., X1 represents C1-6 alkylene, etc., X2 represents C1-6 alkylene, etc., A1 represents a 5- to 6-membered heterocyclic group, etc., and A2 represents C6-14 aryl, etc.
    Type: Application
    Filed: February 9, 2009
    Publication date: October 29, 2009
    Applicant: Eisai R&D Management Co., Ltd.
    Inventors: Fumihiro Ozaki, Motohiro Soejima, Tasuku Ishida, Yoshihiko Norimine, Nobuyuki Kurusu, Eriko Doi, Toshihiko Kaneko, Daiju Hasegawa, Kiyoaki Kobayashi, Noburu Yamamoto
  • Patent number: 7112593
    Abstract: An excellent squalene synthase inhibitor is provided. Specifically, what is provided is a compound (I) represented by the following formula, a salt thereof or a hydrate of them. In formula (I), R1 represents an optionally substituted vinyl group or an aromatic ring which may be substituted. Also, n is an integer of 0 to 2. Further, X, Y and Z are the same as or different from each other and each represents an optionally substituted carbon atom, or an optionally substituted nitrogen atom, sulfur atom or oxygen atom, and Y optionally represents a single bond, and when Y represents the single bond, the ring to which X, Y and Z belong is a 5-membered ring. Also in the formula, CyA represents a 5- to 14 membered non-aromatic cyclic amino group or non-aromatic cyclic amido group which may be substituted, and the non-aromatic cyclic amino group or the non-aromatic cyclic amido group optionally having an oxygen atom or a sulfur atom.
    Type: Grant
    Filed: March 27, 2002
    Date of Patent: September 26, 2006
    Assignee: Eisai Co., Ltd.
    Inventors: Toshimi Okada, Nobuyuki Kurusu, Keigo Tanaka, Seiji Yoshikawa, Daisuke Shinmyo, Nobuhisa Watanabe, Hironori Ikuta, Hironobu Hiyoshi, Takao Saeki, Mamoru Yanagimachi, Masashi Ito
  • Publication number: 20060084658
    Abstract: The present invention provides a novel compound having a superior calcium antagonism, in particular, a neuron-selective calcium antagonism. Namely, it provides a compound represented by the following formula, a salt thereof or a hydrate of them. In the formula, Ar indicates an optionally substituted 5- to 14-membered aromatic ring etc.; the ring A indicates any one ring selected from a piperazine, a homopiperazine, a piperidine and the like; the ring B indicates an optionally substituted C3-14 hydrocarbon ring etc.; E indicates a single bond, a group represented by the formula —CO—, etc.; X indicates a single bond, an oxygen atom etc.; R1 indicates a hydrogen atom, a halogen atom, a hydroxyl group etc.; and D1, D2, W1 and W2 are the same as or different from each other and each represents a single bond or an optionally substituted C1-6 alkylene chain.
    Type: Application
    Filed: September 20, 2005
    Publication date: April 20, 2006
    Inventors: Noboru Yamamoto, Yuichi Suzuki, Manami Kimura, Tetsuhiro Niidome, Yoichi Iimura, Tetsuyuki Teramoto, Yoshihisa Kaneda, Toshihiko Kaneko, Nobuyuki Kurusu, Daisuke Shinmyo, Yukie Yoshikawa, Slinji Hatakeyama
  • Patent number: 6906072
    Abstract: The present invention provides a novel compound having a superior calcium antagonism, in particular, a neuron-selective calcium antagonism. Namely, it provides a compound represented by the following formula, a salt thereof or a hydrate of them. In the formula, Ar indicates an optionally substituted 5- to 14-membered aromatic ring etc.; the ring A indicates any one ring selected from a piperazine, a homopiperazine, a piperidine and the like; the ring B indicates an optionally substituted C3-14 on hydrocarbon ring etc.; E indicates a single bond, a group represented by the formula —CO—, etc.; X indicates a single bond, an oxygen atom etc.; R1 indicates a hydrogen atom, a halogen atom, a hydroxyl group etc.; and D1, D2, W1 and W2 are the same as or different from each other and each represents a single bond or an optionally substituted C1-6 alkylene chain.
    Type: Grant
    Filed: January 18, 2001
    Date of Patent: June 14, 2005
    Assignee: Eisai Co., Ltd.
    Inventors: Noboru Yamamoto, Yuichi Suzuki, Manami Kimura, Tetsuhiro Niidome, Yoichi Iimura, Tetsuyuki Teramoto, Yoshihisa Kaneda, Toshihiko Kaneko, Nobuyuki Kurusu, Daisuke Shinmyo, Yukie Yoshikawa, Shinji Hatakeyama
  • Publication number: 20040220193
    Abstract: The present invention provides a novel compound having a superior calcium antagonism, in particular, a neuron-selective calcium antagonism. Namely, it provides a compound represented by the following formula, a salt thereof or a hydrate of them.
    Type: Application
    Filed: May 28, 2004
    Publication date: November 4, 2004
    Applicant: Eisai Co., Ltd.
    Inventors: Noboru Yamamoto, Yuichi Suzuki, Manami Kimura, Tetsuhiro Niidome, Yoichi Iimura, Tetsuyuki Teramoto, Yoshihisa Kaneda, Toshihiko Kaneko, Nobuyuki Kurusu, Daisuke Shinmyo, Yukie Yoshikawa, Shinji Hatakeyama
  • Publication number: 20040072830
    Abstract: The present invention provides an excellent squalene synthase inhibitor. Specifically, it provides a compound (I) represented by the following formula, a salt thereof or a hydrate of them.
    Type: Application
    Filed: July 30, 2003
    Publication date: April 15, 2004
    Inventors: Toshimi Okada, Nobuyuki Kurusu, Keigo Tanaka, Seiji Yoshikawa, Daisuke Shinmyo, Nobuhisa Watanabe, Hironori Ikuta, Hironobu Hiyoshi, Takao Saeki, Mamoru Yanagimachi, Masashi Ito
  • Patent number: 6599917
    Abstract: The present invention provides an excellent squalene synthesizing enzyme inhibitor. Specifically, it provides a compound (I) represented by the following formula, a salt thereof or a hydrate of them.
    Type: Grant
    Filed: March 19, 2002
    Date of Patent: July 29, 2003
    Assignee: Eisai Co., Ltd.
    Inventors: Toshimi Okada, Nobuyuki Kurusu, Keigo Tanaka, Kazuki Miyazaki, Daisuke Shinmyo, Hiroyuki Sugumi, Hironori Ikuta, Hironobu Hiyoshi, Takao Saeki, Mamoru Yanagimachi, Masashi Ito